Efficacy of NEPA (netupitant/palonosetron) across multiple cycles of chemotherapy in breast cancer patients: A subanalysis from two phase III trials. Read more about Efficacy of NEPA (netupitant/palonosetron) across multiple cycles of chemotherapy in breast cancer patients: A subanalysis from two phase III trials.
Corrigendum to "3rd ESO-ESMO international consensus guidelines for advanced breast cancer (ABC 3)" [Breast 31 (February 2017) 244-259]. Read more about Corrigendum to "3rd ESO-ESMO international consensus guidelines for advanced breast cancer (ABC 3)" [Breast 31 (February 2017) 244-259].
3rd ESO-ESMO international consensus guidelines for Advanced Breast Cancer (ABC 3). Read more about 3rd ESO-ESMO international consensus guidelines for Advanced Breast Cancer (ABC 3).
Time for a randomised clinical trial evaluating breast conserving surgery compared to mastectomy in ipsilateral mutlifocal breast cancer (MFBC)? Read more about Time for a randomised clinical trial evaluating breast conserving surgery compared to mastectomy in ipsilateral mutlifocal breast cancer (MFBC)?
Impact of a primary care based intervention on breast cancer knowledge, risk perception and concern: A randomized, controlled trial. Read more about Impact of a primary care based intervention on breast cancer knowledge, risk perception and concern: A randomized, controlled trial.
ESO-ESMO 2nd international consensus guidelines for advanced breast cancer (ABC2). Read more about ESO-ESMO 2nd international consensus guidelines for advanced breast cancer (ABC2).
Differences in sleep disturbance, fatigue and energy levels between women with and without breast pain prior to breast cancer surgery. Read more about Differences in sleep disturbance, fatigue and energy levels between women with and without breast pain prior to breast cancer surgery.
Additional value of the 70-gene signature and levels of ER and PR for the prediction of outcome in tamoxifen-treated ER-positive breast cancer. Read more about Additional value of the 70-gene signature and levels of ER and PR for the prediction of outcome in tamoxifen-treated ER-positive breast cancer.
1st International consensus guidelines for advanced breast cancer (ABC 1). Read more about 1st International consensus guidelines for advanced breast cancer (ABC 1).
Outcome of long term active surveillance for estrogen receptor-positive ductal carcinoma in situ. Read more about Outcome of long term active surveillance for estrogen receptor-positive ductal carcinoma in situ.
